nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—NR3C1—systemic lupus erythematosus	0.273	1	CbGaD
Cyproterone acetate—Megestrol acetate—Hydrocortisone—systemic lupus erythematosus	0.0893	0.366	CrCrCtD
Cyproterone acetate—Medroxyprogesterone Acetate—Hydrocortisone—systemic lupus erythematosus	0.0794	0.326	CrCrCtD
Cyproterone acetate—Medroxyprogesterone Acetate—Methylprednisolone—systemic lupus erythematosus	0.0749	0.308	CrCrCtD
Cyproterone acetate—NR3C1—Methylprednisolone—systemic lupus erythematosus	0.0616	0.173	CbGbCtD
Cyproterone acetate—NR3C1—Triamcinolone—systemic lupus erythematosus	0.0467	0.131	CbGbCtD
Cyproterone acetate—CYP19A1—Betamethasone—systemic lupus erythematosus	0.0441	0.124	CbGbCtD
Cyproterone acetate—NR3C1—Betamethasone—systemic lupus erythematosus	0.04	0.113	CbGbCtD
Cyproterone acetate—NR3C1—Prednisolone—systemic lupus erythematosus	0.0395	0.111	CbGbCtD
Cyproterone acetate—NR3C1—Hydrocortisone—systemic lupus erythematosus	0.0374	0.105	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—systemic lupus erythematosus	0.0373	0.105	CbGbCtD
Cyproterone acetate—CYP19A1—Dexamethasone—systemic lupus erythematosus	0.0256	0.0721	CbGbCtD
Cyproterone acetate—NR3C1—Dexamethasone—systemic lupus erythematosus	0.0233	0.0655	CbGbCtD
Cyproterone acetate—NR3C1—urine—systemic lupus erythematosus	0.00112	0.137	CbGeAlD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—HIP1—systemic lupus erythematosus	0.000735	0.0681	CbGpPWpGaD
Cyproterone acetate—NR3C1—blood plasma—systemic lupus erythematosus	0.000586	0.0713	CbGeAlD
Cyproterone acetate—Megestrol acetate—NR3C1—systemic lupus erythematosus	0.000517	0.632	CrCbGaD
Cyproterone acetate—CYP19A1—connective tissue—systemic lupus erythematosus	0.000486	0.0592	CbGeAlD
Cyproterone acetate—AR—connective tissue—systemic lupus erythematosus	0.000431	0.0524	CbGeAlD
Cyproterone acetate—AR—skin of body—systemic lupus erythematosus	0.000389	0.0473	CbGeAlD
Cyproterone acetate—AR—kidney—systemic lupus erythematosus	0.000366	0.0446	CbGeAlD
Cyproterone acetate—AR—cortex of kidney—systemic lupus erythematosus	0.000357	0.0435	CbGeAlD
Cyproterone acetate—AR—lymphoid tissue—systemic lupus erythematosus	0.000315	0.0383	CbGeAlD
Cyproterone acetate—NR3C1—connective tissue—systemic lupus erythematosus	0.000312	0.038	CbGeAlD
Cyproterone acetate—NR3C1—nephron tubule—systemic lupus erythematosus	0.000302	0.0368	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—systemic lupus erythematosus	0.000301	0.368	CrCbGaD
Cyproterone acetate—AR—tendon—systemic lupus erythematosus	0.000296	0.036	CbGeAlD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—XRCC6—systemic lupus erythematosus	0.000287	0.0266	CbGpPWpGaD
Cyproterone acetate—NR3C1—skin of body—systemic lupus erythematosus	0.000282	0.0343	CbGeAlD
Cyproterone acetate—CYP19A1—nervous system—systemic lupus erythematosus	0.000272	0.0331	CbGeAlD
Cyproterone acetate—NR3C1—kidney—systemic lupus erythematosus	0.000265	0.0323	CbGeAlD
Cyproterone acetate—CYP19A1—central nervous system—systemic lupus erythematosus	0.000262	0.0319	CbGeAlD
Cyproterone acetate—AR—lung—systemic lupus erythematosus	0.00026	0.0316	CbGeAlD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—systemic lupus erythematosus	0.00026	0.024	CbGpPWpGaD
Cyproterone acetate—NR3C1—cortex of kidney—systemic lupus erythematosus	0.000259	0.0315	CbGeAlD
Cyproterone acetate—CYP19A1—Endogenous sterols—RXRA—systemic lupus erythematosus	0.000243	0.0226	CbGpPWpGaD
Cyproterone acetate—AR—nervous system—systemic lupus erythematosus	0.00024	0.0293	CbGeAlD
Cyproterone acetate—AR—central nervous system—systemic lupus erythematosus	0.000232	0.0282	CbGeAlD
Cyproterone acetate—NR3C1—lymphoid tissue—systemic lupus erythematosus	0.000228	0.0278	CbGeAlD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—RXRA—systemic lupus erythematosus	0.000222	0.0206	CbGpPWpGaD
Cyproterone acetate—NR3C1—tendon—systemic lupus erythematosus	0.000214	0.0261	CbGeAlD
Cyproterone acetate—NR3C1—bone marrow—systemic lupus erythematosus	0.000208	0.0253	CbGeAlD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RASGRP3—systemic lupus erythematosus	0.000204	0.0189	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000189	0.0175	CbGpPWpGaD
Cyproterone acetate—NR3C1—lung—systemic lupus erythematosus	0.000188	0.0229	CbGeAlD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RASGRP3—systemic lupus erythematosus	0.000176	0.0163	CbGpPWpGaD
Cyproterone acetate—NR3C1—nervous system—systemic lupus erythematosus	0.000174	0.0212	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000171	0.0159	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—VDR—systemic lupus erythematosus	0.000169	0.0157	CbGpPWpGaD
Cyproterone acetate—NR3C1—central nervous system—systemic lupus erythematosus	0.000168	0.0204	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000154	0.0143	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.00015	0.0139	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—systemic lupus erythematosus	0.000147	0.0136	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.000145	0.0134	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000144	0.0133	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000144	0.0133	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000144	0.0133	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—systemic lupus erythematosus	0.00014	0.013	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000135	0.0126	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—VDR—systemic lupus erythematosus	0.00013	0.0121	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ETS1—systemic lupus erythematosus	0.000125	0.0116	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—SELE—systemic lupus erythematosus	0.000123	0.0114	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000122	0.0113	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.00012	0.0111	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	0.000118	0.011	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000114	0.0105	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000113	0.0105	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.00011	0.0102	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000109	0.0101	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000109	0.0101	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—RXRA—systemic lupus erythematosus	0.000107	0.0099	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000103	0.00952	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUNB—systemic lupus erythematosus	0.000101	0.00931	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	9.45e-05	0.00875	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	9.36e-05	0.00867	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.16e-05	0.00849	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	9.1e-05	0.00843	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—systemic lupus erythematosus	9.07e-05	0.0084	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CDKN1B—systemic lupus erythematosus	8.79e-05	0.00815	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	8.73e-05	0.00809	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—NAT2—systemic lupus erythematosus	8.68e-05	0.00805	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.56e-05	0.00793	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	8.42e-05	0.0078	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—PRL—systemic lupus erythematosus	8.16e-05	0.00756	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CD4—systemic lupus erythematosus	7.99e-05	0.0074	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	7.92e-05	0.00734	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—systemic lupus erythematosus	7.76e-05	0.00719	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	7.6e-05	0.00704	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL4—systemic lupus erythematosus	7.55e-05	0.007	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	7.53e-05	0.00698	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CDKN1B—systemic lupus erythematosus	7.51e-05	0.00696	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—systemic lupus erythematosus	7.46e-05	0.00691	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—systemic lupus erythematosus	7.25e-05	0.00672	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	7.17e-05	0.00664	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	7.1e-05	0.00658	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	6.95e-05	0.00644	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	6.91e-05	0.0064	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL4—systemic lupus erythematosus	6.65e-05	0.00616	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—EP300—systemic lupus erythematosus	6.6e-05	0.00611	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	6.54e-05	0.00606	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—GADD45A—systemic lupus erythematosus	6.5e-05	0.00602	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	6.29e-05	0.00583	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—ADIPOQ—systemic lupus erythematosus	6.27e-05	0.00581	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—systemic lupus erythematosus	6.06e-05	0.00562	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—systemic lupus erythematosus	6.02e-05	0.00558	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	5.99e-05	0.00555	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.94e-05	0.0055	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	5.71e-05	0.00529	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	5.39e-05	0.00499	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—RXRA—systemic lupus erythematosus	5.37e-05	0.00497	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCL2—systemic lupus erythematosus	5.37e-05	0.00497	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	5.28e-05	0.00489	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	5.2e-05	0.00482	CbGpPWpGaD
Cyproterone acetate—Oedema—Triamcinolone—systemic lupus erythematosus	5.15e-05	0.000479	CcSEcCtD
Cyproterone acetate—Syncope—Dexamethasone—systemic lupus erythematosus	5.13e-05	0.000477	CcSEcCtD
Cyproterone acetate—Syncope—Betamethasone—systemic lupus erythematosus	5.13e-05	0.000477	CcSEcCtD
Cyproterone acetate—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	5.13e-05	0.000477	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—systemic lupus erythematosus	5.11e-05	0.000475	CcSEcCtD
Cyproterone acetate—Hypotension—Hydrocortisone—systemic lupus erythematosus	5.11e-05	0.000475	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—systemic lupus erythematosus	5.08e-05	0.000472	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	5.07e-05	0.000471	CcSEcCtD
Cyproterone acetate—Vomiting—Leflunomide—systemic lupus erythematosus	5.07e-05	0.000471	CcSEcCtD
Cyproterone acetate—Shock—Triamcinolone—systemic lupus erythematosus	5.06e-05	0.000471	CcSEcCtD
Cyproterone acetate—Alopecia—Prednisone—systemic lupus erythematosus	5.06e-05	0.00047	CcSEcCtD
Cyproterone acetate—Shock—Methylprednisolone—systemic lupus erythematosus	5.05e-05	0.00047	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	5.04e-05	0.000469	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	5.04e-05	0.000468	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	5.03e-05	0.000468	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Betamethasone—systemic lupus erythematosus	5.03e-05	0.000468	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	5.03e-05	0.000468	CcSEcCtD
Cyproterone acetate—Rash—Leflunomide—systemic lupus erythematosus	5.03e-05	0.000467	CcSEcCtD
Cyproterone acetate—Tachycardia—Triamcinolone—systemic lupus erythematosus	5.02e-05	0.000467	CcSEcCtD
Cyproterone acetate—Dermatitis—Leflunomide—systemic lupus erythematosus	5.02e-05	0.000467	CcSEcCtD
Cyproterone acetate—Mental disorder—Prednisone—systemic lupus erythematosus	5.02e-05	0.000466	CcSEcCtD
Cyproterone acetate—Nausea—Azathioprine—systemic lupus erythematosus	5.01e-05	0.000466	CcSEcCtD
Cyproterone acetate—Tachycardia—Methylprednisolone—systemic lupus erythematosus	5.01e-05	0.000466	CcSEcCtD
Cyproterone acetate—Headache—Leflunomide—systemic lupus erythematosus	4.99e-05	0.000464	CcSEcCtD
Cyproterone acetate—Skin disorder—Methylprednisolone—systemic lupus erythematosus	4.99e-05	0.000464	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	4.99e-05	0.00462	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Prednisone—systemic lupus erythematosus	4.98e-05	0.000463	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	4.98e-05	0.000463	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	4.97e-05	0.000462	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	4.94e-05	0.00046	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.91e-05	0.000456	CcSEcCtD
Cyproterone acetate—Urticaria—Cyclosporine—systemic lupus erythematosus	4.89e-05	0.000454	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—RXRA—systemic lupus erythematosus	4.87e-05	0.00451	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.86e-05	0.000452	CcSEcCtD
Cyproterone acetate—Abdominal pain—Cyclosporine—systemic lupus erythematosus	4.86e-05	0.000452	CcSEcCtD
Cyproterone acetate—Discomfort—Dexamethasone—systemic lupus erythematosus	4.81e-05	0.000448	CcSEcCtD
Cyproterone acetate—Discomfort—Betamethasone—systemic lupus erythematosus	4.81e-05	0.000448	CcSEcCtD
Cyproterone acetate—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	4.81e-05	0.000447	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000447	CcSEcCtD
Cyproterone acetate—Hypotension—Methylprednisolone—systemic lupus erythematosus	4.8e-05	0.000446	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000445	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000445	CcSEcCtD
Cyproterone acetate—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	4.77e-05	0.000443	CcSEcCtD
Cyproterone acetate—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.75e-05	0.000442	CcSEcCtD
Cyproterone acetate—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.74e-05	0.000441	CcSEcCtD
Cyproterone acetate—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.74e-05	0.000441	CcSEcCtD
Cyproterone acetate—Nausea—Leflunomide—systemic lupus erythematosus	4.73e-05	0.00044	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.72e-05	0.000439	CcSEcCtD
Cyproterone acetate—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.71e-05	0.000438	CcSEcCtD
Cyproterone acetate—Oedema—Dexamethasone—systemic lupus erythematosus	4.67e-05	0.000434	CcSEcCtD
Cyproterone acetate—Oedema—Betamethasone—systemic lupus erythematosus	4.67e-05	0.000434	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.62e-05	0.00043	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.61e-05	0.000429	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000429	CcSEcCtD
Cyproterone acetate—Anaemia—Prednisone—systemic lupus erythematosus	4.61e-05	0.000428	CcSEcCtD
Cyproterone acetate—Shock—Dexamethasone—systemic lupus erythematosus	4.6e-05	0.000427	CcSEcCtD
Cyproterone acetate—Shock—Betamethasone—systemic lupus erythematosus	4.6e-05	0.000427	CcSEcCtD
Cyproterone acetate—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.59e-05	0.000427	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.58e-05	0.000426	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.58e-05	0.000426	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—systemic lupus erythematosus	4.58e-05	0.000426	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.57e-05	0.000425	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.57e-05	0.000425	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—systemic lupus erythematosus	4.56e-05	0.00423	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.56e-05	0.000424	CcSEcCtD
Cyproterone acetate—Tachycardia—Betamethasone—systemic lupus erythematosus	4.56e-05	0.000424	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	4.55e-05	0.00421	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	4.55e-05	0.00421	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	4.54e-05	0.00421	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.53e-05	0.000421	CcSEcCtD
Cyproterone acetate—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.53e-05	0.000421	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.52e-05	0.000421	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.52e-05	0.00042	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.52e-05	0.00042	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.52e-05	0.00042	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.5e-05	0.000419	CcSEcCtD
Cyproterone acetate—Malaise—Prednisone—systemic lupus erythematosus	4.49e-05	0.000418	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	4.49e-05	0.00416	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000416	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.47e-05	0.000416	CcSEcCtD
Cyproterone acetate—Syncope—Prednisone—systemic lupus erythematosus	4.47e-05	0.000416	CcSEcCtD
Cyproterone acetate—Anorexia—Dexamethasone—systemic lupus erythematosus	4.45e-05	0.000414	CcSEcCtD
Cyproterone acetate—Anorexia—Betamethasone—systemic lupus erythematosus	4.45e-05	0.000414	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisolone—systemic lupus erythematosus	4.45e-05	0.000413	CcSEcCtD
Cyproterone acetate—Fatigue—Triamcinolone—systemic lupus erythematosus	4.44e-05	0.000413	CcSEcCtD
Cyproterone acetate—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.43e-05	0.000412	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.42e-05	0.000411	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—EP300—systemic lupus erythematosus	4.41e-05	0.00409	CbGpPWpGaD
Cyproterone acetate—Asthenia—Cyclosporine—systemic lupus erythematosus	4.41e-05	0.00041	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.38e-05	0.000407	CcSEcCtD
Cyproterone acetate—Hypotension—Betamethasone—systemic lupus erythematosus	4.36e-05	0.000406	CcSEcCtD
Cyproterone acetate—Hypotension—Dexamethasone—systemic lupus erythematosus	4.36e-05	0.000406	CcSEcCtD
Cyproterone acetate—Pruritus—Cyclosporine—systemic lupus erythematosus	4.35e-05	0.000405	CcSEcCtD
Cyproterone acetate—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.34e-05	0.000404	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000404	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000402	CcSEcCtD
Cyproterone acetate—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.32e-05	0.000402	CcSEcCtD
Cyproterone acetate—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.32e-05	0.000402	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.31e-05	0.000401	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	4.31e-05	0.00399	CbGpPWpGaD
Cyproterone acetate—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.31e-05	0.0004	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000399	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	4.27e-05	0.00396	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	4.27e-05	0.00395	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.26e-05	0.00395	CbGpPWpGaD
Cyproterone acetate—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.25e-05	0.000395	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.24e-05	0.000394	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—FAS—systemic lupus erythematosus	4.24e-05	0.00393	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.23e-05	0.000393	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—systemic lupus erythematosus	4.23e-05	0.000393	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.21e-05	0.000392	CcSEcCtD
Cyproterone acetate—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.21e-05	0.000391	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.2e-05	0.00039	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisone—systemic lupus erythematosus	4.19e-05	0.00039	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—systemic lupus erythematosus	4.19e-05	0.00039	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—systemic lupus erythematosus	4.17e-05	0.000387	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	4.16e-05	0.00385	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN1B—systemic lupus erythematosus	4.14e-05	0.00384	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.12e-05	0.000383	CcSEcCtD
Cyproterone acetate—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.11e-05	0.000382	CcSEcCtD
Cyproterone acetate—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.11e-05	0.000382	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.11e-05	0.00381	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.11e-05	0.000382	CcSEcCtD
Cyproterone acetate—Urticaria—Triamcinolone—systemic lupus erythematosus	4.09e-05	0.00038	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	4.09e-05	0.00379	CbGpPWpGaD
Cyproterone acetate—Urticaria—Methylprednisolone—systemic lupus erythematosus	4.08e-05	0.000379	CcSEcCtD
Cyproterone acetate—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.07e-05	0.000378	CcSEcCtD
Cyproterone acetate—Dizziness—Cyclosporine—systemic lupus erythematosus	4.07e-05	0.000378	CcSEcCtD
Cyproterone acetate—Oedema—Prednisone—systemic lupus erythematosus	4.07e-05	0.000378	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.06e-05	0.000377	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.06e-05	0.000377	CcSEcCtD
Cyproterone acetate—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.06e-05	0.000377	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—systemic lupus erythematosus	4.06e-05	0.00376	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.03e-05	0.000375	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.03e-05	0.000375	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.03e-05	0.000374	CcSEcCtD
Cyproterone acetate—Fatigue—Betamethasone—systemic lupus erythematosus	4.03e-05	0.000374	CcSEcCtD
Cyproterone acetate—Fatigue—Dexamethasone—systemic lupus erythematosus	4.03e-05	0.000374	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—systemic lupus erythematosus	4.02e-05	0.00373	CbGpPWpGaD
Cyproterone acetate—Shock—Prednisone—systemic lupus erythematosus	4e-05	0.000372	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.99e-05	0.000371	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisone—systemic lupus erythematosus	3.97e-05	0.000369	CcSEcCtD
Cyproterone acetate—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.97e-05	0.000369	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	3.96e-05	0.00367	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Prednisone—systemic lupus erythematosus	3.95e-05	0.000367	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.93e-05	0.000366	CcSEcCtD
Cyproterone acetate—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.92e-05	0.000365	CcSEcCtD
Cyproterone acetate—Vomiting—Cyclosporine—systemic lupus erythematosus	3.91e-05	0.000364	CcSEcCtD
Cyproterone acetate—Rash—Cyclosporine—systemic lupus erythematosus	3.88e-05	0.000361	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—systemic lupus erythematosus	3.88e-05	0.00036	CcSEcCtD
Cyproterone acetate—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.87e-05	0.00036	CcSEcCtD
Cyproterone acetate—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.87e-05	0.00036	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000359	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—MTA2—systemic lupus erythematosus	3.86e-05	0.00358	CbGpPWpGaD
Cyproterone acetate—Headache—Cyclosporine—systemic lupus erythematosus	3.85e-05	0.000358	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—systemic lupus erythematosus	3.85e-05	0.000358	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.85e-05	0.000358	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.85e-05	0.000358	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—systemic lupus erythematosus	3.84e-05	0.00356	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.82e-05	0.000355	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.82e-05	0.000355	CcSEcCtD
Cyproterone acetate—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.82e-05	0.000355	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.79e-05	0.000353	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.78e-05	0.000352	CcSEcCtD
Cyproterone acetate—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.78e-05	0.000352	CcSEcCtD
Cyproterone acetate—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.78e-05	0.000351	CcSEcCtD
Cyproterone acetate—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.76e-05	0.000349	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000349	CcSEcCtD
Cyproterone acetate—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.74e-05	0.000348	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—systemic lupus erythematosus	3.73e-05	0.000347	CcSEcCtD
Cyproterone acetate—Urticaria—Dexamethasone—systemic lupus erythematosus	3.71e-05	0.000345	CcSEcCtD
Cyproterone acetate—Urticaria—Betamethasone—systemic lupus erythematosus	3.71e-05	0.000345	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisolone—systemic lupus erythematosus	3.7e-05	0.000344	CcSEcCtD
Cyproterone acetate—Asthenia—Triamcinolone—systemic lupus erythematosus	3.69e-05	0.000343	CcSEcCtD
Cyproterone acetate—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.69e-05	0.000343	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.69e-05	0.000343	CcSEcCtD
Cyproterone acetate—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.69e-05	0.000343	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.69e-05	0.000343	CcSEcCtD
Cyproterone acetate—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.69e-05	0.000343	CcSEcCtD
Cyproterone acetate—Nausea—Cyclosporine—systemic lupus erythematosus	3.65e-05	0.00034	CcSEcCtD
Cyproterone acetate—Pruritus—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.000339	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EP300—systemic lupus erythematosus	3.64e-05	0.00337	CbGpPWpGaD
Cyproterone acetate—Cough—Methotrexate—systemic lupus erythematosus	3.63e-05	0.000338	CcSEcCtD
Cyproterone acetate—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.000338	CcSEcCtD
Cyproterone acetate—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.62e-05	0.000336	CcSEcCtD
Cyproterone acetate—Dyspepsia—Prednisone—systemic lupus erythematosus	3.58e-05	0.000333	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—systemic lupus erythematosus	3.57e-05	0.00331	CbGpPWpGaD
Cyproterone acetate—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.56e-05	0.000331	CcSEcCtD
Cyproterone acetate—Decreased appetite—Prednisone—systemic lupus erythematosus	3.54e-05	0.000329	CcSEcCtD
Cyproterone acetate—Rash—Prednisolone—systemic lupus erythematosus	3.53e-05	0.000328	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisolone—systemic lupus erythematosus	3.53e-05	0.000328	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.52e-05	0.000327	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.51e-05	0.000327	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—systemic lupus erythematosus	3.51e-05	0.000326	CcSEcCtD
Cyproterone acetate—Headache—Prednisolone—systemic lupus erythematosus	3.51e-05	0.000326	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000326	CcSEcCtD
Cyproterone acetate—Constipation—Prednisone—systemic lupus erythematosus	3.48e-05	0.000323	CcSEcCtD
Cyproterone acetate—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.48e-05	0.000323	CcSEcCtD
Cyproterone acetate—Rash—Hydrocortisone—systemic lupus erythematosus	3.45e-05	0.00032	CcSEcCtD
Cyproterone acetate—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.44e-05	0.00032	CcSEcCtD
Cyproterone acetate—Headache—Hydrocortisone—systemic lupus erythematosus	3.42e-05	0.000318	CcSEcCtD
Cyproterone acetate—Dizziness—Triamcinolone—systemic lupus erythematosus	3.4e-05	0.000316	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	3.4e-05	0.00315	CbGpPWpGaD
Cyproterone acetate—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.4e-05	0.000316	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—systemic lupus erythematosus	3.39e-05	0.00314	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—systemic lupus erythematosus	3.37e-05	0.00312	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.35e-05	0.000312	CcSEcCtD
Cyproterone acetate—Asthenia—Dexamethasone—systemic lupus erythematosus	3.35e-05	0.000312	CcSEcCtD
Cyproterone acetate—Asthenia—Betamethasone—systemic lupus erythematosus	3.35e-05	0.000312	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.33e-05	0.00031	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.33e-05	0.000309	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.33e-05	0.000309	CcSEcCtD
Cyproterone acetate—Nausea—Prednisolone—systemic lupus erythematosus	3.32e-05	0.000309	CcSEcCtD
Cyproterone acetate—Pruritus—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000307	CcSEcCtD
Cyproterone acetate—Pruritus—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000307	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000307	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.29e-05	0.000306	CcSEcCtD
Cyproterone acetate—Vomiting—Triamcinolone—systemic lupus erythematosus	3.27e-05	0.000304	CcSEcCtD
Cyproterone acetate—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.27e-05	0.000304	CcSEcCtD
Cyproterone acetate—Nausea—Hydrocortisone—systemic lupus erythematosus	3.25e-05	0.000302	CcSEcCtD
Cyproterone acetate—Rash—Triamcinolone—systemic lupus erythematosus	3.25e-05	0.000302	CcSEcCtD
Cyproterone acetate—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.24e-05	0.000301	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—SNRPD1—systemic lupus erythematosus	3.24e-05	0.003	CbGpPWpGaD
Cyproterone acetate—Anorexia—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000301	CcSEcCtD
Cyproterone acetate—Rash—Methylprednisolone—systemic lupus erythematosus	3.24e-05	0.000301	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	3.24e-05	0.003	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—systemic lupus erythematosus	3.24e-05	0.003	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.24e-05	0.000301	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—systemic lupus erythematosus	3.23e-05	0.0003	CcSEcCtD
Cyproterone acetate—Headache—Triamcinolone—systemic lupus erythematosus	3.22e-05	0.0003	CcSEcCtD
Cyproterone acetate—Headache—Methylprednisolone—systemic lupus erythematosus	3.22e-05	0.000299	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—systemic lupus erythematosus	3.22e-05	0.000299	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—systemic lupus erythematosus	3.22e-05	0.000299	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—systemic lupus erythematosus	3.21e-05	0.00297	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.2e-05	0.000297	CcSEcCtD
Cyproterone acetate—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.2e-05	0.000297	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—systemic lupus erythematosus	3.18e-05	0.000295	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	3.16e-05	0.00293	CbGpPWpGaD
Cyproterone acetate—Dizziness—Betamethasone—systemic lupus erythematosus	3.09e-05	0.000287	CcSEcCtD
Cyproterone acetate—Dizziness—Dexamethasone—systemic lupus erythematosus	3.09e-05	0.000287	CcSEcCtD
Cyproterone acetate—Nausea—Triamcinolone—systemic lupus erythematosus	3.06e-05	0.000284	CcSEcCtD
Cyproterone acetate—Nausea—Methylprednisolone—systemic lupus erythematosus	3.05e-05	0.000284	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.03e-05	0.000282	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisone—systemic lupus erythematosus	3e-05	0.000279	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000278	CcSEcCtD
Cyproterone acetate—Vomiting—Betamethasone—systemic lupus erythematosus	2.97e-05	0.000276	CcSEcCtD
Cyproterone acetate—Vomiting—Dexamethasone—systemic lupus erythematosus	2.97e-05	0.000276	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000275	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.95e-05	0.00273	CbGpPWpGaD
Cyproterone acetate—Rash—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000274	CcSEcCtD
Cyproterone acetate—Rash—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000274	CcSEcCtD
Cyproterone acetate—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000274	CcSEcCtD
Cyproterone acetate—Dermatitis—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000274	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.93e-05	0.000273	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—MTA2—systemic lupus erythematosus	2.93e-05	0.00272	CbGpPWpGaD
Cyproterone acetate—Fatigue—Methotrexate—systemic lupus erythematosus	2.93e-05	0.000272	CcSEcCtD
Cyproterone acetate—Headache—Betamethasone—systemic lupus erythematosus	2.93e-05	0.000272	CcSEcCtD
Cyproterone acetate—Headache—Dexamethasone—systemic lupus erythematosus	2.93e-05	0.000272	CcSEcCtD
Cyproterone acetate—Asthenia—Prednisone—systemic lupus erythematosus	2.92e-05	0.000271	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—systemic lupus erythematosus	2.88e-05	0.000268	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.8e-05	0.00026	CcSEcCtD
Cyproterone acetate—Diarrhoea—Prednisone—systemic lupus erythematosus	2.78e-05	0.000259	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000258	CcSEcCtD
Cyproterone acetate—Nausea—Betamethasone—systemic lupus erythematosus	2.77e-05	0.000258	CcSEcCtD
Cyproterone acetate—Nausea—Dexamethasone—systemic lupus erythematosus	2.77e-05	0.000258	CcSEcCtD
Cyproterone acetate—Urticaria—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000251	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—systemic lupus erythematosus	2.69e-05	0.00025	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.69e-05	0.00025	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.69e-05	0.00025	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	2.61e-05	0.00242	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	2.59e-05	0.0024	CbGpPWpGaD
Cyproterone acetate—Vomiting—Prednisone—systemic lupus erythematosus	2.59e-05	0.00024	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.58e-05	0.00239	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.58e-05	0.00239	CbGpPWpGaD
Cyproterone acetate—Rash—Prednisone—systemic lupus erythematosus	2.56e-05	0.000238	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—systemic lupus erythematosus	2.56e-05	0.000238	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—systemic lupus erythematosus	2.55e-05	0.000237	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—SNRPB—systemic lupus erythematosus	2.53e-05	0.00234	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	2.53e-05	0.00234	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.5e-05	0.000233	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	2.46e-05	0.00228	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.45e-05	0.00227	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—systemic lupus erythematosus	2.44e-05	0.000227	CcSEcCtD
Cyproterone acetate—Nausea—Prednisone—systemic lupus erythematosus	2.42e-05	0.000225	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—systemic lupus erythematosus	2.41e-05	0.000224	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	2.39e-05	0.00222	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	2.38e-05	0.00221	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.34e-05	0.00217	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—systemic lupus erythematosus	2.33e-05	0.00216	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.33e-05	0.000216	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.26e-05	0.00209	CbGpPWpGaD
Cyproterone acetate—Dizziness—Methotrexate—systemic lupus erythematosus	2.25e-05	0.000209	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.24e-05	0.00207	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	2.23e-05	0.00207	CbGpPWpGaD
Cyproterone acetate—Vomiting—Methotrexate—systemic lupus erythematosus	2.16e-05	0.000201	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.15e-05	0.00199	CbGpPWpGaD
Cyproterone acetate—Rash—Methotrexate—systemic lupus erythematosus	2.14e-05	0.000199	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—systemic lupus erythematosus	2.14e-05	0.000199	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—systemic lupus erythematosus	2.13e-05	0.000198	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	2.11e-05	0.00196	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.11e-05	0.00195	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—systemic lupus erythematosus	2.1e-05	0.00195	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	2.05e-05	0.0019	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.04e-05	0.00189	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	2.03e-05	0.00188	CbGpPWpGaD
Cyproterone acetate—Nausea—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000188	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—TNFSF13—systemic lupus erythematosus	1.98e-05	0.00183	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	1.96e-05	0.00182	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—systemic lupus erythematosus	1.93e-05	0.00179	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SNRPB—systemic lupus erythematosus	1.92e-05	0.00178	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.92e-05	0.00178	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.87e-05	0.00173	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.87e-05	0.00173	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.82e-05	0.00168	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—systemic lupus erythematosus	1.8e-05	0.00167	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.78e-05	0.00165	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.74e-05	0.00162	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.66e-05	0.00153	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.63e-05	0.00151	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.56e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.54e-05	0.00143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAT2—systemic lupus erythematosus	1.48e-05	0.00138	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—systemic lupus erythematosus	1.45e-05	0.00135	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—JUNB—systemic lupus erythematosus	1.42e-05	0.00132	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.26e-05	0.00116	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RXRA—systemic lupus erythematosus	1.24e-05	0.00115	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.24e-05	0.00115	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.18e-05	0.00109	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—systemic lupus erythematosus	1.13e-05	0.00104	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—JUNB—systemic lupus erythematosus	1.08e-05	0.000998	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.06e-05	0.000983	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—systemic lupus erythematosus	1.01e-05	0.00094	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RXRA—systemic lupus erythematosus	9.44e-06	0.000875	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.28e-06	0.00086	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—systemic lupus erythematosus	8.55e-06	0.000792	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—RXRA—systemic lupus erythematosus	8.32e-06	0.000771	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—systemic lupus erythematosus	7.86e-06	0.000728	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.72e-06	0.000715	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—systemic lupus erythematosus	5.96e-06	0.000552	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—systemic lupus erythematosus	5.26e-06	0.000487	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—systemic lupus erythematosus	4.73e-06	0.000438	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—systemic lupus erythematosus	4.52e-06	0.000419	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—systemic lupus erythematosus	4.13e-06	0.000383	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—systemic lupus erythematosus	3.44e-06	0.000319	CbGpPWpGaD
